Enantioselective actions of bupivacaine and ropivacaine on coronary vascular resistance at cardiotoxic concentrations.
The main concern with the use of the long-acting local anesthetics bupivacaine and ropivacaine is inadvertent IV injection, which exposes the heart to toxic drug concentrations. We tested the hypothesis that these chiral anesthetics exert enantioselective actions on coronary vascular tone, the regulation of which does not involve voltage-gated Na(+) channels. Coronary perfusion pressure (CPP) was continuously measured in isolated hearts perfused via the aorta at a constant flow rate. This method provides a sensitive assay of coronary vascular resistance in the intact heart. In parallel experiments, we examined the effects of bupivacaine and ropivacaine on intracellular [Ca(2+)] in coronary endothelial cells. In addition, the effect of bupivacaine on mitochondrial membrane potential was assessed using isolated ventricular myocytes. Racemic bupivacaine and R(+)-bupivacaine produced similar dose-dependent decreases in CPP. However, S(-)-bupivacaine, S(-)-ropivacaine and R(+)-ropivacaine increased CPP. In contrast to adenosine triphosphate, neither racemic bupivacaine nor S(-)-ropivacaine changed endothelial intracellular [Ca(2+)], suggesting that these clinically used drugs do not modulate endothelial nitric oxide synthase. We also showed that the putative uncoupler bupivacaine did not depolarize mitochondria in intact ventricular myocytes. In conclusion, the long-acting local anesthetics have enantioselective actions on coronary resistance vessels. Racemic bupivacaine and R(+)-bupivacaine are coronary vasodilators, whereas S(-)-bupivacaine, S(-)-ropivacaine and, to a lesser extent, R(+)-ropivacaine all induce coronary vasoconstriction.
Burmester
Marko D
MD
Institut für Normale und Pathologische Physiologie, Universität Marburg, Marburg, Germany; Department of Physiology, Physiologisches Institut, Justus-Liebig-Universität, Giessen, Germany.
Schlüter
Klaus-Dieter
KD
Daut
Jürgen
J
Hanley
Peter J
PJ
D000577:Amides / Q000494:pharmacology*; D000779:Anesthetics, Local / Q000494:pharmacology*; D000818:Animals; D002045:Bupivacaine / Q000494:pharmacology*; D002118:Calcium / Q000378:metabolism; D003331:Coronary Vessels / Q000187:drug effects*; D004305:Dose-Response Relationship, Drug; D005905:Glyburide / Q000494:pharmacology; D006168:Guinea Pigs; D024661:Potassium Channels, Inwardly Rectifying / Q000502:physiology; D000077212:Ropivacaine; D013237:Stereoisomerism; D014655:Vascular Resistance / Q000187:drug effects*
D000577:Amides; D000779:Anesthetics, Local; D024661:Potassium Channels, Inwardly Rectifying; D000077212:Ropivacaine; D005905:Glyburide; D002118:Calcium; D002045:Bupivacaine
Blair MR. Cardiovascular pharmacology of local anaesthetics. Br J Anaesth 1975;47:247–52.
Cederholm I, Åkerman B, Evers H. Local analgesic and vascular effects of intradermal ropivacaine and bupivacaine in various concentrations with and without addition of adrenaline in man. Acta Anaesthesiol Scand 1994;38:322–7.
Kopacz DJ, Carpenter RL, Mackey DC. Effect of ropivacaine on cutaneous capillary blood flow in pigs. Anesthesiology 1989;71:69–74.
Graf BM, Abraham I, Eberbach N, et al. Differences in cardiotoxicity of bupivacaine and ropivacaine are the result of physiochemical and stereoselective properties. Anesthesiology 2002;96:1427–34.
Iida H, Ohata H, Iida M, et al. The differential effects of stereoisomers of ropivacaine and bupivacaine on cerebral pial arterioles in dogs. Anesth Analg 2001;93:1552–6.
Daut J, Maier-Rudolph W, von Beckerath N, et al. Hypoxic dilation of coronary arteries is mediated by ATP-sensitive potassium channels. Science 1990;247:1341–4.
von Beckerath N, Cyrys S, Dischner A, Daut J. Hypoxic vasodilatation in isolated, perfused guinea-pig heart: an analysis of the underlying mechanisms. J Physiol 1991;442:297–319.
Hanley PJ, Mickel M, Brandt U, et al. KATP channel-independent targets of diazoxide and 5-hydroxydecanoate in the heart. J Physiol 2002;542:735–41.
Noll T, Muhs A, Besselmann M, et al. Initiation of hyperpermeability in energy-depleted coronary endothelial monolayers. Am J Physiol 1995;268:H1462–70.
Hanley PJ, Loiselle DS. Mechanisms of force inhibition by halothane and isoflurane in intact rat cardiac muscle. J Physiol 1998;506:231–44.
Ray J, Noll F, Daut J, Hanley PJ. Long chain fatty acids increase basal metabolism and depolarize mitochondria in cardiac muscle cells. Am J Physiol 2002;282:H1495–501.
Mederos y Schnitzler M, Derst C, Daut J, Preisig-Müller R. ATP-sensitive potassium channels in capillaries isolated from guinea-pig heart. J Physiol 2000;525:307–17.
Sztark F, Malgat M, Dabadie P, Mazat J-P. Comparison of the effects of bupivacaine and ropivacaine on heart cell mitochondrial bioenergetics. Anesthesiology 1998;88:1340–9.
Nau C, Strichartz GR. Drug chirality in anesthesia. Anesthesiology 2002;97:497–502.
Huang YF, Pryor ME, Mather LE, Veering BT. Cardiovascular and central nervous system effects of intravenous levobupivacaine and bupivacaine in sheep. Anesth Analg 1998;86:797–804.
Chang DH, Ladd LA, Wilson KA, et al. Tolerability of large-dose intravenous levobupivacaine in sheep. Anesth Analg 2000;91:671–9.
Norén H, Lindblom B, Källfelt B. Effects of bupivacaine and calcium antagonists on human uterine arteries in pregnant and non-pregnant women. Acta Anaesthesiol Scand 1991;35:488–91.
Langheinrich U, Mederos y Schnitzler M, Daut J. Ca2+-transients induced by K+ channel openers in isolated coronary capillaries. Pflügers Arch 1998;435:435–8.
Cole WC, Clément-Chomienne O. ATP-sensitive K+ channels of vascular smooth muscle cells. J Cardiovasc Electrophysiol 2003;14:94–103.
Olschewski A, Olschewski H, Bräu ME, et al. Effect of bupivacaine on ATP-dependent potassium channels in rat cardiomyocytes. Br J Anaesth 1999;82:435–8.
Babenko AP, Gonzalez G, Aguilar-Bryan L, Bryan J. Reconstituted human cardiac KATP channels: functional identity with the native channels from the sarcolemma of human ventricular cells. Circ Res 1998;83:1132–43.
Kindler CH, Yost CS, Gray AT. Local anesthetic inhibition of baseline potassium channels with two pore domains in tandem. Anesthesiology 1999;90:1092–102.
Gurney AM, Osipenko ON, MacMillan D, et al. Two-pore domain K channel, TASK-1, in pulmonary artery smooth muscle cells. Circ Res 2003;93:957–64.
Nilius B, Droogmans G. Ion channels and their functional role in vascular endothelium. Physiol Rev 2001;81:1415–59.